31/08/2026
Never underestimate the impact of grassroots community fundraising in supporting early career medical researchers. In 1986, the Queensland and Northern New South Wales Lions Medical Research Foundation funded a bright new molecular biologist, Dr Ian Frazer, to research 4h drugs used in the treatment of AIDS. Dr Frazer was about to return to Scotland, but with this funding was able to move from Melbourne to Brisbane to continue his research. Dr Frazer also had ideas on how immunology might provide a vaccine to prevent cervical cancer...
Without cervical cancer vaccine Gardasil, TRI simply would not exist.
When Co-inventor Emeritus Professor Ian Frazer AC could not manufacture the vaccine in Australia in the 1990s, he was forced to go overseas.
When Gardasil became a global success, Professor Frazer set his sights on establishing an institute where research could be translated from the bench to the bedside – including manufacturing capability. In 2011, he became TRI’s founding CEO.
And now, present CEO Professor Maher Gandhi says TRI is close: “His vision of biomedical manufacturing onsite will finally be realised with the opening of ENTRI.”
A manufacturing facility for vaccines and therapies, ENTRI is due to open in October. ENTRI is proudly funded by the Queensland Government and TRI.
More about ENTRI: https://www.tri.edu.au/entri